Impact of Ayurveda based personalized diet plans on Diabetes Mellitus

Impact of Ayurveda menu plans along with Ayurveda based intensive personal nutritional counselling program on Diabetes Mellitus Type 2: Two arm parallel design randomized control trial - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/085314

Enrollment

146

Registered

2025-04-22

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E11- Type 2 diabetes mellitus

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 2. For Prediabetic condition: A fasting plasma glucose level of 100 to 125 mg/dL (5.55-6.94 mmol/L), 2-hour postload glucose level of 140 to 199 mg/dL (7.77-11.04 mmol/L), HbA1c level of 5.7% to 6.4%, 3. Diagnosed DM Type 2: A fasting plasma glucose level of 126 mg/dL (6.99 mmol/L) or greater upto 200mg/dL (11.1mmol/L), a 2-hour postload glucose level of 200 mg/dL (11.1 mmol/L) or greater up to 280 mg/dL (15.5mmol/L), HbA1c level of 6.5% or 11%. will be included. 4. Any one of these is high.

Exclusion criteria

Exclusion criteria: 1. DM Type 1, DM Type 2 on insulin, Diabetes induced due to endocrinopathies like acromegaly, Cushing syndrome etc. 2. Other diseases like Renal dysfunction, Liver disease, Unmanaged thyroid disease, 3. Chronic alcoholism, 4. Acute or chronic inflammatory diseases. 5. Pregnant, breast feeding women

Design outcomes

Primary

Measure	Time frame
Reduction in FBS by using Ayurveda diet menu plans along with Ayurveda based intensive personal nutritional counselling program.Timepoint: The Baseline, 30th Day, 90th day of intervention period and after 30 days post intervention follow up period.	—

Secondary

Measure	Time frame
1. Reduction in biochemical biomarkers i.e., HbA1C and PPBS. 2. Reduction in other Diabetes Risk factor i.e., S. Insulin, HOMA IR, S. Triglycerides, Tr.G. index. 3. Reduction in CRP, Total Cholesterol. 4. Reduction in BMI, Body weight, Waist Circumference, BP. 5. Reduction in Subjective criteria. Timepoint: The outcome will be assessed at the end of 90 days intervention period and at the end of 30 days post intervention follow up period.	—

Measure

Time frame

1. Reduction in biochemical biomarkers i.e., HbA1C and PPBS. 2. Reduction in other Diabetes Risk factor i.e., S. Insulin, HOMA IR, S. Triglycerides, Tr.G. index. 3. Reduction in CRP, Total Cholesterol. 4. Reduction in BMI, Body weight, Waist Circumference, BP. 5. Reduction in Subjective criteria. Timepoint: The outcome will be assessed at the end of 90 days intervention period and at the end of 30 days post intervention follow up period.

—

Countries

India

Contacts

Public ContactShiva Kumar S Harti

All India Institute of Ayurveda, New Delhi

shivakumarsharti@gmail.com9611275434

Outcome results